Market Research Logo

Asthma Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Asthma Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.

Market Dynamics

Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.

However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).

Key features of the study:

  • This report provides in-depth analysis of the global asthma therapeutics market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global asthma therapeutics market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Asthma Therapeutics Market, By Drug Class:
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • Global Asthma Therapeutics By Route of Administration:
  • Oral
  • Inhalation
  • Injection
  • Global Asthma Therapeutics market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Asthma Therapeutics market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug Class
  • Corticosteroids
  • Beta2-Agonists (Long-Acting and Short-Acting)
  • Leukotriene Inhibitors
  • Long-Acting Muscarinic Antagonists (LAMA)
  • Interleukin Antagonists
  • Anti-Immunoglobulin E (IgE) Agents
  • Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
  • Others
  • By Route of Administration:
  • Oral
  • Intravenous
  • Subcutaneous
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • GlaxoSmithKline Plc.,*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Philips Healthcare
  • AstraZeneca Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim GmbH
  • Sanofi-Aventis SA
  • CareFusion Corporation
  • Sunovion Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Roche Diagnostics.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Epidemiology
Product Recalls
Government Initiatives
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER’S Five Forces
PEST Analysis
4. Global Asthma Therapeutics Market, By Drug Class, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Beta2-Agonists (Long-Acting and Short-Acting)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Leukotriene Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Long-Acting Muscarinic Antagonists (LAMA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Interleukin Antagonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Anti-Immunoglobulin E (IgE) Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids and Others)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
5. Global Asthma Therapeutics Market, By Route of Administration, 2018 – 2026, (US$ Million)
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Inhalation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million
6. Global Asthma Therapeutics Market, By Distribution Chanel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Asthma Therapeutics Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channels, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channels, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
• Heat Map Analysis
• Company Profiles
GlaxoSmithKline Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Philips Healthcare
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AstraZeneca Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Boehringer Ingelheim GmbH
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sanofi- Aventis SA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CareFusion Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sunovion Pharmaceutical Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck & Co. Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Roche Diagnostics
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 23 market data tables and 19 figures on “Asthma Therapeutics Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report